NEW YORK (GenomeWeb) – Life science company LGC announced today that it has acquired a majority stake in laboratory automation company Douglas Scientific.

Douglas Scientific was previously owned by Kingdom Enterprises, and provides high-throughput PCR and qPCR platforms and Array Tape consumables to applied end markets such as agbio and clinical research laboratories. Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.